Dr Christopher A Taylor, DO | |
1223 Swan Dr, Bartlesville, OK 74006-5037 | |
(918) 336-8500 | |
(918) 336-8519 |
Full Name | Dr Christopher A Taylor |
---|---|
Gender | Male |
Speciality | Internal Medicine - Geriatric Medicine |
Location | 1223 Swan Dr, Bartlesville, Oklahoma |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124053178 | NPI | - | NPPES |
100252250B | Medicaid | OK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0300X | Internal Medicine - Geriatric Medicine | 2653 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Christopher A Taylor, DO 1223 Swan Dr, Bartlesville, OK 74006-5037 Ph: (918) 336-8500 | Dr Christopher A Taylor, DO 1223 Swan Dr, Bartlesville, OK 74006-5037 Ph: (918) 336-8500 |
News Archive
DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the signing of a new client with the award of a study for evaluating the use of a thoracic stent graft in aneurysm repair.
Although the use of intraoperative MRI can add time to surgical procedures, it can help surgeons detect residual disease and, if needed, modify their plan for surgery while the patient is on the operating room table, according to a study conducted by researchers at the University Hospitals of Cleveland/Case Western Reserve University in Cleveland, OH and Johns Hopkins University in Baltimore, MD.
In honor of International Women's Day, Africare in partnership with Global Health & Diplomacy (GHD) and the United Nations Foundation (UNF), hosted a panel discussion and press conference focused on issues of health care, women and economic development in Africa and the developing world.
S1 Pharmaceuticals, Inc. (S1) announced today that it has submitted its Investigational New Drug (IND) application to the U.S. Food and Drug Administration for Phase I-b clinical studies of SIP-104 (Lorexys). Lorexys is the Company's lead drug candidate for the treatment of Hypoactive Sexual Desire Disorder (HSDD) and Female Sexual Dysfunction (FSD).
› Verified 4 days ago
Gary T. Dykstra, D.O. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 Se Frank Phillips #502, Bartlesville, OK 74006 Phone: 918-331-2577 Fax: 918-331-2513 | |
Dr. Gerald George Reed, D.O. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3500 E Frank Phillips Blvd, Bartlesville, OK 74006 Phone: 918-333-7200 | |
Zeyfoula Beytoula, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3500 E Frank Phillips Blvd, Bartlesville, OK 74006 Phone: 918-333-7200 | |
Jerry B Jarrell, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1223 Swan Dr, Bartlesville, OK 74006 Phone: 888-777-9170 | |
Samuel Dean Brown, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 226 Se Debell Ave, Bldg. B, Bartlesville, OK 74006 Phone: 918-331-1070 Fax: 918-331-1076 | |
Dr. Anderson P Mehrle, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3460 Se Frank Phillips, Bartlesville, OK 74006 Phone: 918-332-3600 Fax: 918-332-3613 |